Neurobo Pharmaceuticals Inc NRBO shares are trading higher by 77.04% to $0.49 Monday morning after the company announced a 1-for-30 reverse stock split.
The number of authorized shares of the Company's common stock will remain at 100 million, while the number of outstanding shares will be reduced from approximately 26.7 million to approximately 0.9 million.
Beginning Tuesday, the Neurobo Pharmaceuticals' common stock will trade on The Nasdaq Capital Market on a split adjusted basis.
See Also: Why Akari Therapeutics Shares Are Getting Obliterated
According to data from Benzinga Pro, Neurobo Pharmaceuticals has a 52-week high of $4.29 and a 52-week low of $0.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
